- Home
- EBR vs DGX Comparison
EBR vs DGX Comparison
Compare EBR & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBR
- DGX
- Stock Information
- Founded
- EBR 1962
- DGX 1967
- Country
- EBR Brazil
- DGX United States
- Employees
- EBR N/A
- DGX N/A
- Industry
- EBR Electric Utilities: Central
- DGX Medical Specialities
- Sector
- EBR Utilities
- DGX Health Care
- Exchange
- EBR Nasdaq
- DGX Nasdaq
- Market Cap
- EBR 23.3B
- DGX 20.5B
- IPO Year
- EBR N/A
- DGX 1996
- Fundamental
- Price
- EBR $11.03
- DGX $179.50
- Analyst Decision
- EBR
- DGX Buy
- Analyst Count
- EBR 0
- DGX 15
- Target Price
- EBR N/A
- DGX $194.07
- AVG Volume (30 Days)
- EBR 2.2M
- DGX 1.2M
- Earning Date
- EBR 11-05-2025
- DGX 10-21-2025
- Dividend Yield
- EBR 5.48%
- DGX 1.78%
- EPS Growth
- EBR N/A
- DGX 14.49
- EPS
- EBR N/A
- DGX 8.51
- Revenue
- EBR $8,001,033,499.00
- DGX $10,850,000,000.00
- Revenue This Year
- EBR N/A
- DGX $12.37
- Revenue Next Year
- EBR $11.76
- DGX $3.51
- P/E Ratio
- EBR N/A
- DGX $21.08
- Revenue Growth
- EBR 11.98
- DGX 13.74
- 52 Week Low
- EBR $5.45
- DGX $148.70
- 52 Week High
- EBR $11.27
- DGX $197.55
- Technical
- Relative Strength Index (RSI)
- EBR 77.87
- DGX 46.20
- Support Level
- EBR $10.18
- DGX $175.67
- Resistance Level
- EBR $11.27
- DGX $180.04
- Average True Range (ATR)
- EBR 0.18
- DGX 4.65
- MACD
- EBR 0.05
- DGX -0.34
- Stochastic Oscillator
- EBR 81.23
- DGX 19.51
About EBR Centrais Electricas Brasileiras S A (Each representing one Common Share)
Centrais Eletricas Brasileiras SA is engaged in the generation, transmission, and commercialization of electricity in Brazil. The company operates a portfolio of wind, thermal, hydro, and nuclear power plants located throughout the country. Its segments are Generation which consists of the generation of electric energy and the sale of energy to distribution companies and free consumers, and commercialization; Transmission which consists of the transmission of electric energy; and Administration activities mainly represent the Company's cash management, the management of the compulsory loan, and the management of business in SPEs, and others.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.